Related Experiment Video
Updated: May 19, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis
Benjamin C Cheah1, Cindy S Y Lin, Susanna B Park
1Neuroscience Research Australia, Sydney, New South Wales, Australia. M.Kiernan@unsw.edu.au
Objective:
To elucidate longitudinal changes in axonal function in amyotrophic lateral sclerosis (ALS) patients, and to relate such changes with motor unit loss and functional impairment.
Methods:
37 ALS patients (age, 53.7 ± 1.7 years; 22 males) were studied using axonal excitability techniques at baseline and 12 weeks follow-up.
Results:
Longitudinal measurements across excitability parameters suggested increasing K(+) channel dysfunction, with further increases in depolarising threshold electrotonus (90-100 ms, baseline, 46.8 ± 1.0%; follow-up, 48.7 ± 0.8%; P=0.02) and superexcitability (baseline, -24.0 ± 1.2%; 12 weeks, -26.0 ± 1.2%; P=0.04). Patients with preserved compound muscle action potential (CMAP) amplitude at follow-up developed more severe changes in axonal excitability than those in whom CMAP decreased from baseline, suggesting that the most pronounced disease effects were on motor axons immediately prior to axonal loss in ALS patients. Fine motor decline was associated with more severe changes in axonal excitability, suggesting that functional impairment was related to axonal dysfunction.
Conclusions:
Longitudinal changes in axonal excitability in ALS patients suggest increasing K(+) channel dysfunction in motor axons.
Significance:
Axonal excitability studies enable investigation of longitudinal changes in axonal ion channel dysfunction, and thereby the processes that potentially contribute to axonal degeneration in ALS.
Related Concept Videos
Parkinson's Disease: Overview
Multiple Sclerosis l: Introduction
Alzheimer Disease ll: Pathophysiology
Cross-bridge Cycle
Parkinson Disease ll: Pathophysiology
Alzheimer Disease l: Introduction

